Abstract:Microgels acts as a potential candidate for responsive composite materials, which has been favored by scientists because of its excellent colloid stability, easy integration, and most of their surface area can be used as support after modification. Specififically, microgels are fascinating capable of maintaining good biocompatibility and controlled-release in vivo and making the possible for applications in biomaterials and biomedicines. Besides, in the process of microgel synthesis, some targeting factors can be combined to achieve the purpose of cell targeting and uptake. Therefore, how to fundamentally design microgels is an urgent problem to be solved. In this study, we design and synthesize an injectable microgel P(DEGMA-co-OVNGal) that is made of 2-methyl-2-acrylate-2-(2-methoxy ethoxy) ethyl ester (DEGMA) and glycopolymer (OVNGal) that is thermoresponsive and contains galactose. When the content of crosslinking agent is regulated, the microgel will realize the transformation from sol to gel at the temperature around human body, causing the controlled release of the loaded drugs. With the increase of crosslinker content from 1% to 7%, the appearance of microgel changed from loose and ordered to compact and hard morphology, the swelling ratio of microgel decreased from 187% to 142%, and the phase volume transition temperature decreased from 29.2°C to 28°C. The results indicated that when the monomer ratio (DEGMA: OVNGal) increased from 2:1 to 40:1 with the amount of crosslinking agent at 1%, the particle size of microgel increased from 460 nm to 660 nm. In vitro released studies confirmed that the cumulative released DOX (doxorubicin, as a selected model drug) from the microgel can reach 50% after 7 days. Furthermore, in vitro experiments demonstrated that the injectable microgel P(DEGMA-co-OVNGal) can target HepG2 cells effectively and meantime dispalys excellent biocompatibility. Therefore, the injected microgels based on P(DEGMA-co-OVNGal) have the potential to serve as a robust and promising drug delivery carrier for targeted cancer therapy.

Preparation and characterization of galactose-modified liposomes by a nonaqueous enzymatic reaction

Ganoderma Lucidum Polysaccharide Loaded Sodium Alginate Micro-Particles Prepared Via Electrospraying in Controlled Deposition Environments

Preparation of Liposomes Surface-modified with Glycyrrhetinic Acid Targeting to Hepatocytes

In Vitro and in Vivo Studies of Galactose-Modified Liver-Targeting Liposomes.

In Vitro Characteristics of Glucose-Modified Liposomes Using Polyethylene Glycol with Different Chain Lengths As the Linker

Preparation, Characterization and Uptake by Primary Cultured Rat Hepatocytes of Liposomes Surface-Modified with Glycyrrhetinic Acid.

Preparation of Glycyrrhetinic Acid Liposomes Using Lyophilization Monophase Solution Method: Preformulation, Optimization, and In Vitro Evaluation

Construction of Efficacious Hepatoma-Targeted Nanomicelles Non-Covalently Functionalized with Galactose for Drug Delivery

A Novel Glycyrrhetinic Acid-Modified Oxaliplatin Liposome for Liver-Targeting and in Vitro/vivo Evaluation.

Synthesis and Characterization of a New Cationic Galactolipid with Carbamate for Gene Delivery

Preparation of Long-Circulating Lipoplexes Modified with Glycyrrhetinic Acid

Synthesis of Multivalent Galactosides as Targeting Ligand for Gene Delivery

Synthesis of a Novel Multivalent Galactoside with High Hepatocyte Targeting for Gene Delivery

Galactose-functionalized injectable thermosensitive microgels for target specific uptake in hepatoma cells

Synthesis, Characterization and in Vitro Evaluation of Self-Assembled Poly(ethylene Glycol)-Glycyrrhetinic Acid Conjugates

Preparation and in Vitro Characterization of Propylgallate Liposomes

Quality-by-Design-Based Development of n-Propyl-Gallate-Loaded Hyaluronic-Acid-Coated Liposomes for Intranasal Administration

Modified zinc oxide nanoparticles as potential drug carrier

PREPARATION AND CHARACTERIZATION OF GLYCYRRHETINIC ACID-MODIFIED POLOXAMER 188/CHITOSAN NANOPARTICLES

Study on Encapsulation Efficiency and In-vitro Release of Glycyrrhetinic Acid Liposomes

Galactose-functionalized Multi-Responsive Nanogels for Hepatoma-Targeted Drug Delivery